1. Exposure to serum from exclusive heated tobacco product smokers induces mTOR activation and fibrotic features in human cardiac stromal cells.
- Author
-
Picchio, Vittorio, Pagano, Francesca, Carnevale, Roberto, D'Amico, Alessandra, Cozzolino, Claudia, Floris, Erica, Bordin, Antonella, Schirone, Leonardo, Vecchio, Daniele, Saade, Wael, Miraldi, Fabio, De Falco, Elena, Sciarretta, Sebastiano, Peruzzi, Mariangela, Biondi-Zoccai, Giuseppe, Frati, Giacomo, and Chimenti, Isotta
- Subjects
- *
HEART cells , *HEART fibrosis , *TOBACCO products , *STROMAL cells , *VASCULAR endothelial growth factors - Abstract
Chronic smokers have increased risk of fibrosis-related atrial fibrillation. The use of heated-tobacco products (HTPs) is increasing exponentially, and their health impact is still uncertain. We aim to investigate the effects of circulating molecules in exclusive HTP chronic smokers on the fibrotic behavior of human atrial cardiac stromal cells (CSCs). CSCs were isolated from atrial tissue of elective cardiac surgery patients, and exposed to serum lots from young healthy subjects, stratified in exclusive HTP smokers, tobacco combustion cigarette (TCC) smokers, or nonsmokers (NS). CSCs treated with TCC serum displayed impaired migration and increased expression of pro-inflammatory cytokines. Cells cultured with HTP serum showed increased levels of pro-fibrotic markers, and reduced expression of connexin-43. Both TCC and HTP sera increased collagen release and reduced secretion of angiogenic protective factors from CSCs, compared to NS serum. Paracrine support to tube-formation by endothelial cells and to viability of cardiomyocytes was significantly impaired. Treatment with sera of both smokers groups impaired H 2 O 2 /NO release balance by CSCs and reduced early phosphorylation of several pathways compared to NS serum, leading to mTOR activation. Cotreatment with rapamycin was able to reduce mTOR phosphorylation and differentiation into aSMA-positive myofibroblasts in CSCs exposed to TCC and HTP sera. In conclusion, the circulating molecules in the serum of chronic exclusive HTP smokers induce fibrotic behavior in CSCs through activation of the mTOR pathway, and reduce their beneficial paracrine effects on endothelial cells and cardiomyocytes. These results point to a potential risk for cardiac fibrosis in chronic HTP users. [Display omitted] • Smoking represents a risk factor for cardiac fibrosis and atrial fibrillation. • The use of heated tobacco products (HTPs) is raising exponentially • The impact of heated tobacco products on health is still uncertain. • The serum of chronic HTP smokers activates human atrial fibroblasts. • The chronic use of HTPs could increase the risk of cardiac fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF